Polymorphism at the -308-promoter position of the tumor necrosis factor-alpha (TNF-α) gene and cervical cancer

International Journal of Gynecological Cancer

Volumn 13, Issue 2, 2003, Pages 148-153

  Stanczuk, G A ^a,b,c   Sibanda, E N ^a   Tswana, S A ^a   Bergstrom, S ^b  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIV OF ZIMBABWE MEDICAL SCHOOL   (Zimbabwe)

Author keywords

Cervical cancer; Cytokine gene polymorphism; TNF ; Zimbabwe

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; DNA;

ADULT; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; DNA PURIFICATION; ETHNIC GROUP; EUROPE; FEMALE; GEL ELECTROPHORESIS; GENE AMPLIFICATION; HOMOZYGOSITY; HUMAN; HUMAN CELL; HYPOTHESIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MEDICAL SCHOOL; POLYMERASE CHAIN REACTION; POPULATION; PRIORITY JOURNAL; PROMOTER REGION; TEACHING HOSPITAL; UNIVERSITY; URINE; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; ZIMBABWE; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; MULTICENTER STUDY; NUCLEIC ACID AMPLIFICATION; PATHOLOGY; UTERINE CERVIX TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DNA, NEOPLASM; FEMALE; HUMANS; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA; UTERINE CERVICAL NEOPLASMS; ZIMBABWE;

EID: 0037969843     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2003.13046.x     Document Type: Article

References (36)

1. Bornstein J, Lahat N, Kinarty A, Revel M, Abramovici H, Shapiro S. Interferon-beta and gamma, but not tumor necrosis factor-alpha, demonstrate immunoregulatory effects on carcinoma cell line infected with human Papillomavirus. Cancer 1997;79:924-34.
2. Magnusson PKE, Sparen P, Gyllensten UB. Genetic link to cervical tumours. Natare 1999;400:29-30.
3. Stanczuk GA, Sibanda EN, Perrey C et al. Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production. Int J Cancer 2001;94:792-4.
4. Leibovich SJ, Polverini PJ, Shepard HM et al. Macrophage-induced angiogenesis is mediated by tumor necrosis factor. Nature 1987;329:630-2.
5. Dinh TV, Hannigan E, Smith ER, Hove MJ, Chopra V, To T. Tumor angiogenesis as a predictor of recurrence in stage Ib squamous cell carcinoma of the cervix. Obstet Gynecol 1996;87:751-3.
6. Grosen EA, Yamamoto RS, Ioli G et al. Blocking factors I soluble membrane receptors for tumor necrosis factor and lymphotoxin detected in ascites and released in short-term cultures obtained from ascites and solid tumors in women with gynecologic malignancy. Lymph Cyt Res 1992;11:347-53.
7. Woodworth CD, McMullin E, Iglesias M, Plowman GD. Interleukin 1 alpha and tumour necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human Papillomavirus-immortalized and carcinoma-derived cervical epithelial cells. Proc Natl Acad Sci USA 1995;92:2840-4.
8. Chopra V, Dinh TV, Hannigan EV. Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer. Cancer Invest 1998;16:152-9.
9. Marino MW, Pfeffer LM, Guidon PT Jr, Donner DB. Tumour necrosis factor induces phosphorylation of a 28-kDa mRNA cap-binding protein in human cervical carcinoma cells. Proc Natl Acad Sci USA 1989;86:8417-21.
10. Vieira KB, Goldstein DJ, Villa LL. Tumour necrosis factor alpha interferes with the cell cycle of normal and papillomavirus-immortalized human keratinocytes. Cancer Res 1996;56:2452-7.
11. Kono K, Ressing ME, Brandt RM et al. Decreased expression of signal-transducing zeta chain in peripheral T cell and natural killer cells in patients with cervical cancer. Clin Cancer Res 1996;2:1825-8.
12. Powell CB, Scott JH, Collins JL. Characterization of the protein synthesis independent TNF-alpha lytic mechanism in human ovarian and cervical carcinoma cell line. Gynecol Oncol 1996;62:42-8.
13. Powell CB, Scott JH, Collins JL. Comparison of TNF-alpha and TNF-beta cytolytic mechanisms in human ovarian and cervical carcinoma cell lines. Gynecol Oncol 1998;71:258-65.
14. Verma VN, Shenoy CN, Nadkarni JJ. Augmentation of cisplatin cytotoxicity using cytokines on cervical carcinoma cell lines. Cancer Biotherapy Radiopharmaceuticals 1996;11:349-54.
15. Rangel R, Rocha L, Ramirez JL et al. Generation of memory CD4+, CD8+, CD45RO+ and CD16- lymphocytes activated with IL-2, INF-gamma, and TNF-alpha with specific cytotoxicity against autologous cervical cancer cells in a mixed leukocyte-tumour cell culture. Eur Cytokine Network 1995;6:195-202.
16. Hambek M, Solbach C, Schnuerch HG et al. Tumor necrosis factor alpha sensitizes low epidermal growth factor receptor (EGFR) -expressing carcinomas for anti-EGFR therapy. Cancer Res 2001;61:1045-9.
17. Suk K, Chang I, Kim YH et al. Interferon gamma (IFN-gamma) and tumour necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFN-gamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways. J Biol Chem 2001;276:13153-9.
18. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff G. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-9.
19. Turner DM, Grant SC, Lamb WR, et al. A genetic marker of high TNF-α production in heart transplant recipients. Transplantation 1995;60:1113-7.
20. Braun J, Yin Z, Spiller S et al. Low secretion of tumour necrosis factor alpha but no other Th1 or Th2 cytokines by peripheral blood mononuclear cells correlates with chronicity in reactive arthritis. Arthritis Rheum 1999;42:2039-44.
21. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor alpha promoter polymorphism effects transcription. Mol Immunol 1997;34:391-9.
22. Chen G, Wilson R, Wang SH, Zheng HZ, Walker JJ, McKillop JH. Tumour necrosis factor-alpha (TNF-α) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol 1996;104:154-9.
23. Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV. ARMS-PCR methodologies to determine IL-10, TNF-α and TGF-β1 gene polymorphism. Transplant Immunol 1999;7:127-8.
24. Gallagher G, Eskdale J, Oh H-H, Richards SD, Campbell DA, Field M. Polymorphisms in the TNF gene cluster and MHC serotypes in the West of Scotland. Immunogenetics 1997;45:188-94.
25. Krul EJ, Schipper RF, Schreuder GM, Fleuren GJ, Kenter GG, Melief CJ. HLA and susceptibility to cervical neoplasia. Hum Immunol 1999;60:337-42.
26. Hildesheim A, Schiffman M, Scott DR et al. Human leukocyte antigen class I/II alleles and development of human Papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States. Cancer Epidemiol Biomarkers Prev 1998;7:1035-41.
27. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8 and DR3 alleles. J Exp Med 1993;177:557-60.
28. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-11.
29. Kersemaeker A-MF, Kenter GG, Hermans J, van de Vijver MJ. Allelic loss and prognosis in carcinoma of the cervix. Int J Cancer 1998;79:411-7.
30. Kersemaeker A-MF, van de Vijver MJ, Kenter GG, Fleuren GJ. Genetic alteration during the progression of squamous cell carcinoma of the uterine cervix. Genes Chromosomes Cancer 1999;26:346-54.
31. Harima Y, Sawada S, Nagata K, Sougawa M, Ohnishi T. Chromosome 6p21.2 18q21.2 and human papilloma virus (HPV) DNA can predict prognosis of cervical cancer after radiotherapy. Int J Cancer 2001;96:286-96.
32. Beesley JS, Kirby PL, Takeda S, Stackpoole A, Soutter WP, White JO. The growth response to tumour necrosis factor alpha of human gynecological cancer cell lines. Cytokine 1998;10:432-40.
33. Howell EA, Chen Y-T, Concato J. Differences in cervical cancer mortality among black and white women. Obstet Gynecol 1999;94:509-15.
34. Perrey C, Pravica V, Sinnott PJ, Hutchinson IV. Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming factor-β 1 and tumour necrosis factor-α genes: a technical report. Transplant Immunol 1998;6: 193-7.
35. Sullivan KE, Wooten C, Schmeckpeper BJ, Goldman D, Petri M. A promoter polymorphism of tumour necrosis factor α associated with systemic lupus erythematosus in African-Americans. Arth Rheum 1997;40:2207-11.
36. Cabera M, Shaw MA, Sharples C et al. Polymorphism in tumour necrosis factor gene associated with mucocutaneous leishmaniasis. J Exp Med 1995;182:1259-64.